UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate®

Medline ® Abstract for Reference 33

of 'Risks associated with epilepsy and pregnancy'

33
TI
Antiepileptics and the development of congenital anomalies.
AU
Yerby MS, Leavitt A, Erickson DM, McCormick KB, Loewenson RB, Sells CJ, Benedetti TJ
SO
Neurology. 1992;42(4 Suppl 5):132.
 
We are conducting a prospective cohort study of epilepsy and pregnancy to determine the nature and extent of adverse pregnancy outcomes in infants of mothers with epilepsy (IME). Women with epilepsy were enrolled no later than the first trimester and were matched with controls; their infants were examined at 8 weeks by pediatricians blinded to maternal status. A number of variables were compared between case and control infants: birth weight, length, gestational age, head circumference, Apgar scores, feeding difficulties, neonatal irritability, and presence of major malformations and minor anomalies. The number of minor anomalies per infant was greater for IME than for controls (mean, 5.05 and 3.65, p less than 0.0001 per infant, respectively). Prominent occiput was the only anomaly seen significantly more often in IME than in controls (p less than 0.05).
AD
Oregon Comprehensive Epilepsy Program, Portland 97210.
PMID